Corcept director granted 12,500 stock options
Corcept Therapeutics director Joshua M. Murray received a grant of stock options covering 12,500 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics director Joshua M. Murray received a grant of stock options covering 12,500 shares of Common Stock. The options have an exercise price of $59.69 per share and expire on May 21, 2036.
The award vests ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, conditioned on his continued service on each monthly vesting date. Following the grant, he holds 12,500 stock options directly, with no sales reported in this filing.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
Murray Joshua M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Key Figures
Options granted: 12,500 options
Exercise price: $59.69 per share
Expiration date: May 21, 2036
+2 more
5 metrics
Options granted
12,500 options
Stock Option (right to buy) granted to director on May 21, 2026
Exercise price
$59.69 per share
Exercise price for the 12,500 stock options
Expiration date
May 21, 2036
Option award expiration
Underlying shares
12,500 shares
Common Stock underlying the option grant
Post-grant derivative holdings
12,500 options
Total stock options held following this transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 59.6900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-21T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative securities financial
"transaction_type: derivative"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Corcept Therapeutics (CORT) report for Joshua M. Murray?
Corcept Therapeutics reported that director Joshua M. Murray received a grant of 12,500 stock options. These derivative securities give him the right to buy Common Stock at a fixed exercise price, with no shares bought or sold in the market in this filing.
What is the exercise price of Joshua M. Murray’s new Corcept (CORT) stock options?
The newly granted stock options to director Joshua M. Murray carry an exercise price of $59.69 per share. This means he can purchase Corcept’s Common Stock at that price once the options vest, subject to the award’s terms and his continued service.
How do Joshua M. Murray’s Corcept (CORT) stock options vest under this grant?
The 12,500 stock options vest ratably in equal installments on each monthly anniversary of May 21, 2026 over one year. Vesting is conditioned on Murray’s continued service on each monthly vesting date, so unvested portions depend on him remaining in his director role.
When do Joshua M. Murray’s newly granted Corcept (CORT) stock options expire?
The stock options granted to director Joshua M. Murray expire on May 21, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Corcept Therapeutics Common Stock under this specific award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
